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The Naprapath in the
Rainforest
By John D. Blum*
I. Introduction
Naprapathyl is one of several forms naprapaths: Illinois and New Mexico.
of Complementary and Alternative With a total of less than 500 licensed spe-
Medicine (CAM) that makes up the broad cialists, it seems unlikely that this small
and somewhat murky area referred to as set of CAM professionals will have a
manipulative and body based therapies. 2  strong impact on American health pol-
There are only two states that license icy.3 But if naprapathy is added to the
* John D. Blum is the John J. Waldron Research Professor of Law at Loyola University Chicago School of
Law, Beazley Institute for Health Law and Policy. Special thanks to Dr. Patrick Nuzzo D.N., President of the
Southwest University of Naprapathic Medicine and Health Sciences for his friendship, and help and support in
preparing this article.
1. Naprapathy is "the evaluation of persons with connective tissue disorders through the use of
naprapathic case history and palpation or treatment of persons by the use of connective tissue manipulation,
therapeutic and rehabilitative exercise, postural counseling, nutritional counseling, and the use of the effective
properties of physical measures of heat, cold, light, water radiant energy, electricity, sound and air, and assis-
tive devices for the purpose of preventing, correcting or alleviating a physical disability." See Jane Fresne,
D.N., What is Naprapathy?, DR. JANE FRESNE, D.N., http://www.drfresne.com/naprapathy.htm (last visited
May 30, 2013).
2. See National Center for Complementary and Alternative Medicine, National Institutes of Health,
What is Complementary and Alternative Medicine?, U.S. DEP'T OF HEALTH & HuMAN SERVS. (Feb. 2013), http://
nccam.nih.gov/health/whatiscam. For purposes of this article, the focus on CAM is largely directed toward
licensed CAM providers of manipulative and body based therapy. Areas such as osteopathic medicine and
physical therapy that use manipulative techniques are not covered, as they have achieved integration with
allopathic medicine.
3. The exact number of naprapaths is hard to gauge, but based on data from New Mexico and Illinois, the
number of licenses may be less than 400. According to the Illinois Department of Financial and Professional
Regulation, 284 licenses have been issued for the practice of naprapathy (letter on file with author, Feb. 28,
2013). There are individuals who use the title of "naprapath" in states other than New Mexico and Illinois who
are licensed in one of these two respective states. In addition, there are individuals who may hold the title of
"naprapath" based on historic licensure but are in jurisdictions that do not currently license naprapaths, such
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ranks of other licensed CAM providers in
manipulative therapies, particularly chi-
ropractors and massage therapists, the
numbers become significant and consti-
tute a more distinct presence.4
While the idea of CAM is hardly
novel, it still exists in a netherworld of
health care. CAM is paradoxically perva-
sive, but CAM is still only mildly em-
braced by the medical establishment,
which accepts CAM "therapies" believing
that these therapies do no harm and may
have some type of placebo effect.5 With
the exception of chiropractic, CAM thera-
pies may largely be a compliment to allo-
pathic medicine. However, for individuals
with certain medical conditions, CAM is
not just a casual pursuit, as the arma-
ments of biomedical healing have not
ameliorated their suffering.e In particu-
lar, patients with intractable pain often
find themselves at a point where the best
of established medicine may be limited in
potential and dangerous in prospect.7 It is
at the point, where allopathic pathways
may not be fruitful, that conservative,
drug-free approaches offered by licensed
specialists in manipulative therapies
(and possibly other areas of CAM) may
hold promise for supporting necessary
public health efforts." Certainly questions
of efficacy will likely persist when consid-
ering any form of CAM, but in the
shadows of the Patient Protection and Af-
fordable Care Act (ACA), the inquiries
should expand into questions that probe
how certain practices in this arena can be
utilized to address public health needs
and more broadly support national goals
in the areas of cost effectiveness, access,
and system redesign.
This essay is not written as a broad-
based endorsement of complementary
and alternative medicine, but rather
presents a more modest case for patient
use of state-licensed CAM professionals
who specialize in manipulative therapies
to be incorporated into health reform ef-
as Ohio. See Grandfather Provisions for Naprapaths and Mechanotherapists, OmIo REVISED CODE § 4731.151(1990), available at http://codes.ohio.gov/ore/4731.151.
4. See National Center for Complementary and Alternative Medicine, Massage Therapy: An Introduc-
tion, U.S. DEP'T OF HEALTH & HUMAN SERVS. (Aug. 2010) available at http://nceam.nih.gov/health/massage/
massageintroduction.htm#status; See also The Future of Chiropractic Revisited: 2005 to 2015, INST. FOE ALTER-
NATIVE FUTURES, Jan. 2005, available at http://www.altfutures.com/pubs/health/Future%20ofo2OChiropractic
%20Revisted%20v1.pdf.
5. See RICHARD KRADIN, THE PLACEBO RESPONSE AND THE POWER OF UNCONScious HEALING 226-36(2008). For a compelling account of the integration of conventional therapy with CAM in a young boy withjuvenile idiopathic arthritis, see Susannah Meadows, The Boy with a Thorn in his Joints, THE N.Y. TIMES
MAGAZINE, Feb. 1, 2013, at MM32, http://www.nytimes.com/2013/02/03/magazine/the-boy-with-a-thorn-in-his-
joints.html?pagewanted=all&_r=0.
6. See Meadows, supra note 5. Here, the term biomedical healing is a generic one that refers to the
application of science to clinical medicine, with a focus on biological treatment and healing, which contrasts
with health care treatment that is holistically based.
7. See National Center for Complementary and Alternative Medicine, Chronic Pain and CAM: At a
Glance, U.S. DEPT OF HEALTH & HUMAN SERVS. (Dec. 2012), http://nccam.nih.gov/health/pain/chronic.htm.
8. See id. In 2011, the Institute of Medicine issued a report, which identified pain as a major American
public health issue. See also Committee on Advancing Pain Research, Care, and Education; Institute of
Medicine, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Re-
search, INST. OF MED. (2011).
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forts. The proposed framework for ex-
panded CAM utilization, offered in this
piece, is driven by growing pressures on
the healthcare system to identify new
and creative ways to respond to existing
demands, as well as the host of new chal-
lenges triggered by the need for more pre-
ventive and wellness services. This
article contends that the ACA doesn't
merely present challenges to meet ex-
panding public demands, but affords op-
portunities for innovations that should
incorporate the use of licensed CAM spe-
cialists particularly in areas that concern
pain management, and more specifically,
chronic lower back pain.9
The article is divided into three sec-
tions. The first section provides a back-
ground discussion on the ACA,
highlighting key elements of the law that
hold significance for the integration of
CAM services.' 0 The other portion of the
background discussion explores the pub-
lic health dimensions of chronic illnesses.
This portion suggests that CAM ap-
proaches to these massive problems, par-
ticularly in reference to pain, should be
considered within the framework of ACA
innovation. The second section of the arti-
cle presents three sets of arguments for
expanding the orbit of CAM manipulative
therapy into the health reform arena, in-
cluding building coverage through inte-
gration with statutory provisions in the
ACA - particularly Section 2706, a non-
discrimination provision - and reconsid-
ering key elements in the lexicon of CAM
legitimacy. The third section looks at
pathways for creative uses of CAM, draw-
ing loosely on ideas for organizational in-
novation detailed in management
literature. The piece posits a model for
expansion of manipulativetherapies
within the area of chronic lower back
pain, incorporating such services into a
Patient Centered Medical Home
(PCMH)." A deliberate, focused use of
certain CAM therapies, such as licensed
naprapathy, can both spark innovations
in delivery and provide a vehicle to more
effectively assess the utility of manipula-
tive therapies, beyond the scope of cur-
rently available clinical efficacy studies.
II. Background
A. Key Elements
Dramatic changes in the landscape of
health care insurance and policy have
been ushered in by the passage of the
ACA and its companion bill, the Reconcil-
iation Act.12 Not since the enactment of
9. See Mark A. Jackson, & Karen H. Simpson, Chronic Back Pain, 6 BRITISH J. OF ANESTHESIA, 152-55
(2006), http://ceaccp.oxfordjournals.orglcontent/6/4/152.full.pdftml; see also Carol Colwell, Chronic Back Pain
is on the Rise, U.S. NEWS AND WORLD REPORT, Feb.10, 2009, http://health.usnews.comL/health-news/family-
health/pain/articles/2009/02/10/chronic-low-back-pain-is-on-the-rise.
10. See Estimates for the Insurer Coverage Provisions of the Affordable Care Act Updated for the Recent
Supreme Court Decision, CONG. BUDGET OFFICE (July 2012), available at http://www.cbo.gov/sites/default/files/
cbofiles/attachments/43472-07-24-2012-CoverageEstimates.pdf.
11. See ALAN H. GOROLL & ALBERT G. MULLEY, PRIMARY CARE MEDICINE: OFFICE EVALUATION AND MAN-
AGEMENT OF THE ADULT PATIENT 1023-38 (6th ed. 2009).
12. See Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148, 124 Stat. 119 (2010)
(codified as amended at 42 U.S.C. § 18001); see also Health Care and Educ. Reconciliation Act of 2010, Pub. L.
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Medicare and Medicaid laws in the 1960s
has there been such wide-sweeping re-
form undertaken in health care, one that
literally touches on all sectors of the en-
terprise and will chart government ef-
forts for years to come.13 Fundamentally,
the ACA concerns the expansion of health
insurance, and it achieves coverage ex-
tensions in public and private programs
through a series of reform measures that
reflect the interplay between these two
sectors characteristic of our health sys-
tem.14 Among the more notable private
sector provisions, the ACA mandates that
individuals obtain insurance, that pre-ex-
isting condition exclusions and prohibi-
tions on annual and lifetime coverage
limitations be abolished, and that there
be minimum benefit packages created. "
The ACA expands Medicare drug cover-
age and provides premium supports and
tax credits for individuals and small busi-
nesses to purchase insurance.16 In addi-
tion, the ACA creates new state-based
health insurance purchasing programs,
known as health insurance exchanges,
and allows for states to expand Medicaid
programs to new populations using fed-
eral funds.17
The ACA could not achieve broad re-
forms in health insurance and large-scale
extensions of coverage without address-
ing an array of other issues that lie at the
core of the health care enterprise, namely
cost and efficiency. While the ACA, like
most massive pieces of legislation, may
not be a seamless web of interconnected
measures, a critical number of cost con-
tainment and structural reforms must
work reasonably well to ensure af-
fordability, and requisite efficiencies
must be present in order to sustain
health insurance expansions. On the cost
side, at the macro level, the reform
scheme must reduce government health
expenditures, as well as introduce multi-
ple strategies to spark future cost ap-
proaches to access and quality; as such, a
significant number of measures in the
law are directed to reducing expenses
and increasing revenues.' It is estimated
that the reform law will cut $716 billion
out of Medicare over a ten year period,
and those cuts, combined with new taxes,
No. 111-152, 124 Stat. 1029 (2010) (codified as amended at 42 U.S.C § 1305). (Collectively referred to as
"ACA").
13. See Arnold J. Rosoff, Of Stars and Proper Alignment: Scanning the Heavens for the Future of Health
Care Reform, 159 U. PA. L. REV. 2083, 2087 (2011).
14. See Nan D. Hunter, Health Insurance Reform and Intimations of Citizenship, 159 U. PA. L. REV. 1955
(2011).
15. Other key private sector reforms include discontinuance of rate setting based on health status and
gender, limiting premium variations based on age, adopting community rating based on geography, creating
disincentives for insurers' spending more than 20% on administrative costs (80/20 rule), and limiting policy
rescissions. See John K. DiMugno, The Future of the Patient Protection and Affordable Care Act, aka "Obama-
care", 24 CAL. INS. L. & REG. REP. 1, 2 (2012).
16. See id.
17. See id.
18. See Dennis M. Barry, Charles A. Luband, & Holley Thames Lutz, The Impact of Healthcare Reform
Legislation on Medicare, Medicaid and CHIP, Am. HEALTH LAWYERS Ass'N (2010), available at http://www
.healthlawyers.org/Events/Programs/Materials/Documents/HCR10/barryluband lutz.pdf.
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fees, and enhanced fraud and abuse regu-
lations, create a floor of fiscal viability.19
On the structural side, the ACA
launches an array of initiatives to im-
prove quality and patient safety and to
foster innovations in delivery systems
such as Accountable Care Organizations
(ACOs) and Patient Centered Medical
Homes (PCMHs).20 The renovated deliv-
ery systems result in a more coordinated,
patient-centric system, which, in turn,
link up to prior Administration simplifi-
cation efforts concerning adoption of elec-
tronic health record systems.21 While
there are multiple developments in the
architecture of health care that can be
culled out of the ACA and that promote
systemic changes, three areas stand out
as capstones of system reorientation and
highlight the balances between cost and
quality that must be struck to insure the
viability of the ACA scheme.22 First, the
National Strategy for Quality Improve-
ment in Health Care ("National Strat-
egy") is a core element of the ACA that
sparks a process for developing a
roadmap for healthcare directions that
underscores a strong intersection of indi-
vidual and public health measures cap-
tured in this law.23
Second, in support of the National
Strategy noted, the ACA contains an ar-
19. The question of by how much the ACA should cut Medicare was hotly contested in the 2012 presiden-
tial election campaign; See, e.g., Sarah Kliff, Romney's Right: Obamacare Cuts Medicare by $716 Billion: Here's
How, WASH. POST, Aug. 14, 2012, available at http://www.washingtonpost.com/blogs/wonkblog/wp/2012/08/14/
romneys-right-obamacare-cuts-medicare-by-716-billion-heres-how/. Starting in 2014, a series of new taxes and
fees required by the ACA will begin to kick in. See generally Billy Hallowell, Here's a List of Tax Hikes & Fees
Coming With Obamacare Next Year, THE BLAZE (Dec. 25, 2012), http://www.theblaze.com/stories/2012/12/25/
heres-a-list-of-tax-hikes-fees-coming-with-obamacare-next-year/. At this point the financial realities underpin-
ning the ACA are still evolving. No doubt, the cost issues had to be addressed in order to get the legislation
enacted, but the future will be one in which issues of affordability will be constant companions of those en-
trusted with the oversight and administration of public and private health insurance; See Reed Abelson,
Health Insurers Raise Some Rates by Double Digits, N.Y. TIMES, Jan. 5, 2013, available at http://www.nytimes
.com/2013/01/06/business/despite-new-health-law-some-see-sharp-rise-in-premiums.html?pagewanted=all& r
=0.
20. For a summary of ACA's key provisions, see Focus on Health Reform, THE HENRY J. KAISER FAMILY
FOUND. (Apr. 15, 2011), http://www.kff.org/healthreformi/upload/8061.pdf. While the ACA has launched a mas-
sive array of health initiatives, it is clearly built off existing programs such as Medicare and Medicaid, as well
as a host of regulatory programs at the federal and state levels that affect health insurance, employee benefits
and tax laws. One major initiative that must be seen as part of the panoply of established and evolving health
reforms is the Hi-Tech Act, which is designed to spark the implementation and development of electronic
medical records that are so central to the architecture of health delivery. See 45 C.F.R. § 170 (2010).
21. See 45 C.F.R. § 170 (2010).
22. The three areas noted, the National Strategy for Quality Improvement, prevention and wellness, and
health innovations in delivery models and research are all vital elements in health system restructuring, but
they have been highlighted here as they are also significant elements in making a case for integrating CAM
therapies into the ACA reform efforts.
23. See Agency for Healthcare Research & Quality, 2012 Annual Progress Report to Congress: National
Strategy Report for Quality Improvement in Health Care, U.S. DEP'T OF HEALTH & HUMAN SERVS. 1-2 (Aug.
2012), available at http://www.ahrq.gov/workingforquality/nqs/nqs20l2annlrpt.pdf. In this report, the Depart-
ment of Health and Human Services (DHHS) outlines six priorities: patient safety, individual and family part-
nership, communication and coordination of care, prevention and treatment of the leading causes of mortality
(cardiovascular disease), community involvement and the development, and spread of new, innovative health
delivery systems.
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ray of measures that are directed toward
enhancement of preventive and wellness
services, and the Act marks a significant
and deliberate foray into this traditional
area of public health. The efforts under-
taken in the ACA concerning prevention
and wellness may be cast in a traditional
biomedical model, but the efforts are cer-
tainly reflective of governmental aware-
ness that broader public health
approaches, including information
awareness, clinical prevention, and work-
place wellness, are critical for health
maintenance and potentially play impor-
tant roles in containing costs of chronic
illness.24
Third, the ACA creates two new qual-
ity initiatives that are bookends of sys-
tem redesign: the Center for Medicare
and Medicaid Innovation (CMMI) and the
Patient Centered Outcomes Research In-
stitute (PCORI). 2 5 CMMI is geared to-
ward supporting cost effective
innovations in an array of outpatient and
inpatient settings. 2 6 PCORI promotes
clinical effectiveness research (CER)
projects, tracks the National Strategy,
and should generate clinical tools to sup-
port the innovations in practice and de-
sign that flow from CMMI efforts.27
Another key set of elements in the
legislative infrastructure of health re-
form concerns measures that need to be
pursued for the ACA to meet its goals of
providing meaningful insurance cover-
age, particularly human resource devel-
opment. It is indisputable that expanded
access to health insurance must be ac-
companied by meaningful strategies that
provide the necessary compliment of
providers to deliver this health care.
Clearly, the expansion of health insur-
ance coverage to 29 million Americans
necessitates an adequate supply of health
providers to deal with this new popula-
tion of insureds.28 In addition, with grow-
ing numbers of aging Americans, the
need for more primary care resources had
to be confronted in the ACA; although,
like most long-standing problems in
health care, it is one laden with economic
and political complexities, calling for
multiple solutions.29 In recognition of the
severity of primary care shortages exper-
ienced, especially by poor populations,
the ACA increases primary care Medicaid
rates to Medicare levels.Ao More gener-
24. For a detailed discussion of the role of public health in the ACA, see Micah L. Berman, A Public
Health Perspective on Health Care Reform, 21 HEALTH MATRIx 352, 353-56 (2011), available at http://papers
.ssrn.com/sol3/papers.cfm?abstract id=1917706.
25. See Our Mission, CTR. FOR MEDICARE AND MEDICAID INNOVATIONS (CMMI), available at http://
www.innovations.cms.gov/About/Our-Mission/index.html; 42 U.S.C. § 1315(a) (2010); Mission and Values, PA-
TIENT CENTERED OUTCOMES RES. INST. (PCORI), available at http://www.pcori.org/about/mission-and-vision/;
42 U.S.C. § 1320 (2012).
26. See Our Mission, supra note 25.
27. See Mission and Values, supra note 25.
28. See Elayne J.Heisler, Physician Supply and the Affordable Care Act, CONG. RESEARCH SERVICE 2
(Jan. 15, 2013), available at http://op.bna.com/hl.nsflid/myon-93zpre/$File/crsdoctor.pdf.
29. See Uwe E. Reinhardt, Health-Care Reform and the "Doctor Shortage", N.Y. TIMES, Aug. 17, 2012,
available at http://economix.blogs.nytimes.com/2012/08/17/health-care-reform-and-the-doctor-shortage/.
30. See 42 C.F.R. §§ 438, 441 and 447.
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ally, the ACA contains an extensive num-
ber of measures focused on expanding the
health care workforce. The measures
range from development of human re-
source innovation policies, efforts to in-
crease the numbers of primary care
physicians and nurses, initiatives to
strengthen the dental workforce, in-
creased support for health education and
training, and the creation of new educa-
tion entities focused on community
health and primary care teaching health
centers.31
While much of the workforce focus in
the ACA revolves around primary care
physician shortages, the legislative effort
is far more expansive in addressing
human resource capacities across a wide
continuum of health providers. The law
creates a National Health Care
Workforce Commission to become the key
actor in this area whose mandate in-
cludes policy developments affecting an
expansive array of health professionals,
including chiropractors and licensed com-
plementary and alternative health prac-
titioners. 3 2 Like cost and system redesign,
shoring up healthcare human resources
is a matter of fostering policy innovations
that enhance access. Without major re-
forms in the workforce, the promise of
healthcare expansion will not be realized.
Equally fundamental to the access
question is a guarantee that the scope of
coverage (what the ACA actually insures
under its auspices) represents a mean-
ingfully comprehensive array of neces-
sary medical services. To insure
adequacy of coverage, the ACA mandates
that minimum essential benefits be af-
forded for individuals and small busi-
nesses accessing coverage on health
insurance marketplaces and that those
'benefits' requirements apply to Medicaid
as well. 33 The Secretary of the U.S. De-
partment of Health and Human Services
(DHHS) is charged with developing a reg-
ulatory framework for health insurance
plans that guarantees comprehensive-
ness, non-discrimination, comparability
to traditional employer plans and catego-
rization based on value.3 4 All plans of-
fered under the auspices of the ACA must
not only meet federal standards to be-
come qualified health plans, but are also
required to fulfill dictates of benchmarks
31. For an overview of the array of measures taken in the Affordable Care Act, see generally National
Workforce Policy Development, HEALTH REFORM GPS: NAVIGATING IMPLEMENTATION (Oct. 3, 2010), available at
http://healthreformgps.org/topics/workforce-and-access/. (Most workforce measures are found in Title V of the
ACA).
32. See generally H.R. 3590 § 5101(i)(1), 111th Cong. (2010) (listing of health care professionals).
33. See 42 U.S.C. § 18021 (2010); State Health Insurance Mandates and the PPACA Essential Benefits
Provisions, NAT'L CONFERENCE OF STATE LEGISLATUREs (Feb. 20, 2013), http://www.ncsl.org/issues-research/
health/state-ins-mandates-and-aca-essential-benefits.aspx; see also Essential Health Benefits: HHS Informa-
tional Bulletin, U.S. DEP'T OF HEALTH & HUMAN SERVS. (Feb. 24, 2012), available at http://www.healthcare
.gov/news/factsheets/2011/12/essential-health-benefits12162011a.html; SMD Letter 12-003 from Cindy Mann,
Director, Center for Medicaid & CHIP Services to State Medicaid Directors, RE: Essential Health Benefits in
the Medicaid Program (Nov. 20, 2012), available at http://www.medicaid.gov/Federal-Policy-Guidance/down
loads/SMD-12-003.pdf.
34. See Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148, 124 Stat. 163 (2010)
(codified as amended at 42 U.S.C. § 18001); 42 U.S.C. § 2707(a) (2007).
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set by states within which they operate,
which could entail inclusion of mandates
not contained in the federal law.35 While
there is room for variability built into the
coverage offered by ACA qualified health
plans, there are ten coverage areas that
must be included, and if all ten are not
present, explicit supplemental coverage
in other targeted areas must be pro-
vided. 36 It is noteworthy that in the list of
ten coverage targets, preventive and
wellness services are specifically man-
dated in the law as noted, underscoring
the fundamental nature of public health-
oriented services in the ACA scheme.3
B. Chronic Illness and Pain
The interrelationship between sys-
tem redesign, necessary changes in cost
containment, revenue generation, human
resource innovation and meaningful
health insurance coverage go a long way
to explain the architecture of the ACA
(and subsequent regulatory develop-
ments). But the goals of the law are also
rooted in federal responses to the most
pressing medical needs of current and fu-
ture patient populations. No area of need
is more central to the health reform ini-
tiatives of the ACA than addressing the
multiple challenges posed by chronic ill-
nesses.
An eclectic array of lifelong and
rarely curable conditions and chronic ill-
nesses affect half of all Americans. They
are the leading cause of death and disa-
bility in the United States, accounting for
three-quarters of health spending."1 The
list of chronic diseases includes arthritis,
asthma, chronic respiratory conditions,
diabetes, heart disease, HIV infection,
hypertension and obesity, among others.
These chronic diseases challenge all sec-
tors of the health delivery enterprise and
cause particular concerns in light of our
aging population and the staggering asso-
ciated costs.39 The ability to address
chronic illness across its wide swath is
35. States may develop benchmark plans that include coverage mandates that are not specified in the
federal law or in the plan accreditation process. See 45 C.F.R. §§ 156.20 and 156.275 (2012). States that choose
to add additional coverage mandates after 2011 may incur cost sharing responsibilities to do so. Those states
that default and fail to select a benchmark plan will have the largest small market plan in their jurisdiction
used as the benchmark. See 45 C.F.R. § 156.100(c) (2012).
36. See Amanda Cassidy, Essential Health Benefits, HEALTH AFFAIRS (Apr. 25, 2012), available at http:l
healthaffairs.org/healthpolicybriefs/ brief pdfs/healthpolicybrief_68.pdf.
37. See 45 C.F.R. § 156.110 (2013).
38. See Living Well with Chronic Illness: A Call for Public Health Action, INST. OF MED. (Jan. 31, 2012),
available at http://iom.edulReports/2012/Living-Well-with-Chronic-Illness.aspx; How Health Care Reform Can
Improve Care for People With Chronic Health Conditions, BAZELON CTR. FOR MENTAL HEALTH LAw (2012),
http://www.bazelon.org/LinkClick.aspx?fileticket=TfBiX-DlvaQ%3D&tabid=218. For a commentary on chronic
disease costs in the context of Illinois, see Caitlin Padula, The Affordable Care Act: Preventing Chronic Dis-
eases, THE SHRIVER BRIEF (Feb.2, 2012), http://www.theshriverbrief.org/2012/02/articles/health-care-justice/
the-affordable-care-act-preventing-chronic-diseases/.
39. See Chronic Conditions: A Challenge for the 21st Century, NAT'L ACAD. ON AN AGING Soc'v (Nov.
1999), available at http://www.agingsociety.org/agingsociety/pdf/chronic.pdf; see also Michael Ricciardelli, The
Demographics of Illness and Cost: or, an Old Story About Chronic Conditions, SETON HALL HEALTH REFORM
WATCH (June 28, 2011), available at http://www.healthreformwatch.com/2011/06/28/the-demographics-of-ill
ness-and-cost-or-an-old-story-about-chronic-conditions/.
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fundamental to the integrity of any
healthcare system reform, and that rec-
ognition is clearly manifested throughout
the ACA.4 0 Many of the broad measures
noted earlier in this piece, like innova-
tions in delivery models and reinvention
of the health care workforce, are exam-
ples of measures that are tightly linked to
combating chronic illnesses. Certainly,
key ACA health insurance provisions,
such as the elimination of pre-existing
condition exclusions and removal of cov-
erage limitations, are designed to combat
coverage challenges faced by those suffer-
ing from ongoing chronic health
problems.41 Although there are a surpris-
ing number of specific initiatives in the
ACA directed at particular chronic health
problems, the law establishes a frame-
work within which to address chronic
care broadly, as opposed to creating com-
prehensive programs to target individual
diseases. 4 2
Dealing with chronic illness requires
setting priorities in this area and target-
ing specific conditions for action.43 The
problem of targeting is compounded by
the reality that many adults suffer from
multiple chronic illnesses and combating
these diseases requires cohesive ap-
proaches to care, which have been diffi-
cult to achieve.4 4 In a recently published
report, the Institute of Medicine (IOM)
explored dimensions of chronic illness
from a medical, social, and public health
perspective with a focus on how our
health system can be improved to assist
individuals to "live well."45 The IOM re-
port was written to expand the role of
public health in chronic illness. This ex-
panded role must comport with the
framework of the ACA.46 The IOM did not
prioritize diseases but rather chose what
it referred to as nine "exemplars", which
are conditions where a multisectoral ap-
proach could improve the quality of life,
assist functioning, reduce disability, and
fit within the policy framework of the
Centers for Disease Control to engage in
"winnable" battles .
40. See Anand K. Parekh, Help for People With Multiple Chronic Conditions, U.S. DEP'T OF HEALTH AND
HuMAN SERVS. (Sept. 7, 2012), available at http://www.healthcare.gov/blog/2012/09/hfpwmccO9O7l2.html.
41. See 42 U.S.C. § 300gg(3) (2011).
42. The ACA establishes a number of measures that are specific to a given chronic disease, such as
diabetes and obesity, but the ACA certainly does not include any disease that falls under the broad rubric of
chronic disease. However, this area of healthcare is central to the health reform measures, as the future of
health reform will rest in large part on confronting population health challenges that are so extensive in this
area.
43. See Living Well with a Chronic Illness, supra note 38, at 69.
44. See Virginia M. Freid, Amy B. Bernstein & Mary Ann Bush, Multiple Chronic Conditions Among
Adults Aged 45 and Over: Trends Over the Past 10 Years, CTas. FOR DISEASE CONTROL & PREVENTION (July 31,
2012), available at http://www.cdc.gov/nchs/data/databriefs/db100.htm?s-cid=fb-nchsO78#percentage; see also
Mary E. Tinetti, Terri R. Fried & Cynthia M. Boyd, Designing Health Care for the Most Common Chronic
Condition - Multimorbidity, 307 JAMA 2493, 2493-94 (2012).
45. See Living Well with a Chronic Illness, supra note 38.
46. See id.
47. See id. at 9-10; The IOM targeted chronic conditions with cross-cutting clinical, functional, and social
implications, non-duplicative of other illnesses for which public health programs have been devised (i.e. cardio-
vascular disease, stroke), those models of care important for chronic disease, those affecting various organ
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While the nine conditions noted by
the IOM have great significance for pub-
lic health, it is notable that, in the con-
text of this essay, one of the exemplars
highlighted for particular focus was
chronic pain .4 Interestingly enough, this
is one chronic illness that was specifically
noted in the ACA. The law mandates
both the Secretary of DHHS and the Di-
rector of the National Institutes of Health
to direct activities aimed at reducing bar-
riers to pain control and to promote ef-
forts in clinical research in the pain
area.49
The specific nature of responses to
chronic illnesses are still unfolding, but
based on individual provisions and the
broader programmatic frameworks of re-
form, it seems reasonable to argue that
illnesses such as uncontrollable pain fall
clearly within the ambit of federal health
policy. In light of key ACA focal points
considered herein - economics, system
redesign, quality of care and human re-
source needs - an array of possibilities for
innovations in confronting chronic illness
should be considered.5o
In seeking approaches to chronic ill-
ness, a related question arises as to how
broad and open innovation really is in the
ACA context generally. By and large, a
review of the ACA, in whole or part, leads
to the conclusion that reform is largely
cast within the context of the biomedical
system that currently exists and that in-
novation largely flows out of redesigned
medical models of delivery.l But a more
liberal reading of innovation in the wake
of the ACA could possibly result in incor-
porating non-allopathic models into cer-
tain aspects of a restructured health
system that meet some of the fundamen-
tal reform goals noted earlier in this
piece. In particular, the area of chronic
pain appears to be a fruitful one for al-
lowing the ambit of reform possibilities to
include complementary and alternative
medicine practitioners.
Addressing chronic pain is a health
problem that fits into a historic and pre-
sent role filled by CAM practitioners, cov-
ering a range of practices that use non-
drug approaches to treat this area.5 2 Rel-
ative to one major area of chronic pain -
systems, and those variations in clinical manifestations and outcomes that hold promise for public health
interventions.
48. See id. at 9.
49. See Patient Protection and Affordable Care Act of 2010, Pub. L. No. 111-148, § 4305 (2010) (codified
as amended at 42 U.S.C. § 18001). This section mandates a study on pain that was completed by the IOM and
titled "Relieving Pain in America." It explores the multifaceted elements of pain from a public health perspec-
tive. Additionally, this section requires NIH to create an Interagency Taskforce on Pain to promote an agenda
for basic and clinical research in this field. This section of the legislation does not develop specific pain control
programs, but it certainly is a testament to the awareness of the government for the need to address this
pivotal area of chronic illness.
50. Any possibility for innovation must, of course, fit within the legal framework of the ACA and be
compatible with relevant federal and state laws.
51. The innovations that run through the ACA are byproducts of system redesign and are ones largely
structured from rearranging current parts of the existing system.
52. See National Center for Complementary and Alternative Medicine, Chronic Pain and CAM: At a
Glance, U.S. DEP'T OF HEALTH & HumA SERVS. (Sept. 2011), available at http://nccam.nih.gov/health/pain/
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lower back pain - there is both a body of
research and a number of endorsements
from traditional medical organizations
that support the use of such therapy as a
conservative modality of treatment.53 A
particularly compelling reason for ex-
panding the platform of ACA innovation
to the use of CAM therapies in pain man-
agement is that there are serious
problems with drug dependence and ad-
diction in this area that could be miti-
gated with non-pharmacological
interventions.5 4 Additionally, and equally
significant, is a growing awareness not
only of safety and quality, but also of the
appreciation that non-traditional thera-
pies may also provide more cost-effective
approaches to pain therapy as compared
to the more extensive and riskier inter-
ventions like surgery.5 5
III. Building a Case for CAM
The idea of expanding CAM therapy
is not a new one. There have been con-
certed attempts to license and insure a
wide array of non-traditional services,
and these attempts have, notably, gar-
nered a certain amount of success. 5 6 The
controversies between traditional
medicine and CAM may have abated to
an extent and equilibrium has been
achieved, if not acceptance for use of al-
ternative treatment for some conditions
such as chronic pain, as previously
noted.57 The question thus arises, in light
chronic.htm; see generally Chiropractic Manipulation and Medical Care for Low Back Pain, U.S. NATL INST. OF
HEALTH (Feb. 18, 2011), available at http://clinicaltrials.gov/show/NCT01211 6 13 .
53. In 2007, the American College of Physicians and the American Pain Society included spinal manipu-
lation as one of several treatment options for practitioners to consider when low-back pain does not improve
with self-care. See Roger Chou et. al., Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice
Guideline from the American College of Physicians and the American Pain Society, ANNALS OF INTERNAL MED.
(Oct. 2, 2007), http://annals.org/article.aspx?articleid= 7 3 6 8 14 . See also University of Ottawa Evidence-based
Practice Center, Complementary and Alternative Therapies for Back Pain II, AGENCY FOR HEALTHCARE RE-
SEARCH AND QUALITY 1, 89 (2010), http://www.ahrq.gov/research/findings/evidence-based-reports/backcam
2
-ev-
idence-report.pdf, which found that spinal manipulation was more effective than placebo and as effective as
medication in relieving back pain.
54. See Maia Szalavitz, Are Doctors Too Reluctant to Prescribe Opioids?, TIME (Feb. 24, 2010), available
at http://www.time.com/time/health/article/0,8599,19647
8 2
,00.html. Overutilization and underutilization of
opioids can lead to problems in the area of opioids and make non-drug regimens attractive and less costly. See
also Jennifer Gunter, Why the American Problem with Opioids and Chronic Pain is Here to Stay, MEDPAGE
TODAY (Feb. 22, 2013), http://www.kevinmd.com/blog/2013/02/american-problem-opioids-chronic-pain-stay
.html.
55. The University of Pittsburg Medical Center Health Plan issued a well-publicized policy stating that it
would require more conservative therapy for three months (including chiropractic) prior to approving lower
back surgery for pain, which reflects the intersection of quality and cost considerations in this area; See Treat-
ment of Chronic Low Back Pain, UPMC HEALTH PLAN (Dec. 2011), available at http://www.upmchealthplan
.com/pdf/Dec 2011 PPU.pdf. See also Spinal Manipulation Proves Equally Beneficial as Surgery in Sciatica
Treatment, MED. NEWS TODAY (May 11, 2011), available at http://www.medicalnewstoday.com/releases/2
2 4 9 5 7
.php (discussing conclusions of a study that found spinal manipulations as effective for sciatica patients as
surgery).
56. See Kathleen M. Boozang, Is the Alternative Medicine? Managed Care Apparently Thinks So, 32
CONN. L. REV. 567 (2000).
57. See David Kretzmann, The Flexner Report's Stranglehold on Health Care, DAVIDKRETZMAN.COM (Nov.
19, 2009), http://davidkretzmann.com/2009/11/the-flexner-report%E2%80%99s-stranglehold-on-health-care/.
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of the prior discussion on ACA chal-
lenges, whether the case can be made for
expanding the ambit of health care in
ways that allow CAM to be incorporated
into the new arenas of health reform.
This piece posits three approaches to
building the case for a more expanded
role for non-traditional medicine: (1) us-
ing the ACA directly, (2) considering four
related elements that have been raised in
CAM acceptance discussions for many
years, and (3) constructing a case for con-
servative expansion of CAM based on a
broad and specific reading of the concept
of innovation interwoven throughout the
ACA.
A. On the Face of the Law
A review of the ACA's legislative his-
tory, text, and resultant regulations does
not easily lead to the conclusion that
CAM plays a role in health care reform.5*
Rather, there is a noticeable absence in
the law, the penumbra of policy debate,
and the discussion about the ACA regard-
ing the uses of non-traditional medicine
in a transformed health system; the na-
tional discussion and the resultant work
products have been dominated by a bi-
omedical vision of health care.59 Never-
theless, there are numerous provisions
contained within the ACA that advance
the case for greater inclusion of licensed
CAM providers both broadly and in the
context of specialized programs. 60 In ad-
dition, general policy initiatives in the
ACA, like PCORI and CMMI, can be seen
as a springboard for promoting CAM in-
clusion.61
In particular, three sections of the
ACA stand out as foundational platforms
on which to mount an argument for a
wider use of CAM in the health reform
context. The first is Section 3502, which
creates funding for the establishment of
Community Health Teams to support pa-
tient-centered medical homes.62 The
teams will be designed to support com-
prehensive, coordinated, community-
based care and are to be interdisciplinary
in nature; moreover, the law specifically
allows for use of CAM practitioners and
chiropractors as team members.63 The
second is Section 5101 and, as previously
58. Clearly advocates of CAM would disagree, as they have strongly argued that the ACA builds a foun-
dation for a major role of licensed CAM. See Case for Full and Non-Discriminatory Inclusion of DCs in
America's Health System, Am. CHIROPRACTIC Ass'N, http://www.acatoday.org/content css.cfm?CID=4445.
59. See generally Gwendolyn Roberts Majette, Healthcare Reform & The Missing Voice of Complemen-
tary and Alternative Medicine, 10 Hous. J. HEALTH L. & POL'y 35 (2010).
60. See John Weeks, Patient Protection and Affordable Healthcare Act (HR 3590): Sections Directly Re-
lated to CAM and Integrative Practices, THE INTEGRATOR BLOG (May 12, 2010), http://theintegratorblog.com/
site/index.php?option=com-content&task=view&id=658&Itemid=2.
61. In its first round of grant awards, PCORI funded a number of grants. For a list of awardees, see
Michael J. Schneider, A Comparison of Non-Surgical Treatment Methods for Patients with Lumbar Spinal
Stenosis, PATIENT CENTERED OUTCOMES RESEARCH INST. (Dec. 18, 2012), available at http://www.pcori.org/as
sets/PFA-Awards-Cycle-1-2012.pdf.
62. See 42 U.S.C. 256a-1 § 3502 (2010).
63. See 42 U.S.C. 256a-1 §3502(b)(4) (2010); See also Ellen Andrews, Patient-Centered Medical Homes in
the Patient Protection and Affordable Care Act, CONN. HEALTH POL'Y PROJECT (May 16, 2010), available at
http://www.cthealthpolicy.org/medicalhome/20100516-pcmh-and-federal.pdf.
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noted, it mandates the creation of a
healthcare workforce taskforce to be the
focal point in human resource develop-
ment, and it specifically includes licensed
CAM providers in its definition.- The
third, and presumably the most signifi-
cant provision in the ACA regarding
CAM inclusion, is a non-discrimination
provision that applies to some CAM prov-
iders. 6 5 Under the non-discrimination
provision, insurers offering group or indi-
vidual health insurance coverage are pro-
hibited from discriminating against any
licensed or certified health provider act-
ing within his or her respective scope of
practice parameters. 6 6 The non-discrimi-
nation section, Section 2706, is not an
"any willing provider" provision that
would require inclusion of a CAM practi-
tioner in a given health insurance policy
nor does it require uniform payment
rates.6 7
The nondiscrimination section of
ACA resembles nondiscrimination provi-
sions contained in Medicaid and the
Medicare Modernization Act, as well as
provisions found in state law.66 While not
a coverage mandate, the nondiscrimina-
tion provision has been hailed by CAM
provider organizations as a significant
foray into non-traditional medicine that
will, going forward, force insurers to in-
clude CAM in areas where coverage is
mandated.6 9 It appears that the section is
self-executing, and there is also evidence
in DHHS rules that the agency intends to
enforce the nondiscrimination provision
in reference to multi-state health insur-
ance plans to be offered on new health in-
surance exchange beginning in 2014, but
a specific case for provider nondiscrimi-
nation here is more remote.70 In addition
to the federal nondiscrimination provi-
sion in Section 2706, individual states
64. See H.R. 3590 § 5101(i)(1) (2010).
65. See 42 U.S.C. § 300gg-5(a) (2010). A group health plan and a health insurance issuer offering group
or individual health insurance coverage shall not discriminate with respect to participation under the plan or
coverage against any health care provider who is acting within the scope of that provider's license or certifica-
tion under applicable State law. This section shall not require that a group health plan or health insurance
issuer contract with any health care provider willing to abide by the terms and conditions for participation
established by the plan or issuer. Nothing in this section shall be construed as preventing a group health plan,
a health insurance issuer, or the Secretary from establishing varying reimbursement rates based on quality or
performance.
66. See id. (The Section was added in the Senate version of ACA.)
67. See id. "Any willing provider" is a provision which requires a health plan to contract with any pro-
vider who is willing to meet the terms and conditions of the plan and accept its reimbursement rates; See Any
Willing Provider, Am. HEALTH LAWYERs Ass'N (Aug. 10, 2012), http://www.healthlawyers.org/hlresources/
Health%20Law%2OWiki/Any%2OWilling%20Provider.aspx.
68. See 42 U.S.C. § 1396u2 (2010); 42 U.S.C. § 1932(b)(7); 42 C.F.R. § 422.205 (2011); see also West's
R.C.W.A. 48.43.045 (2008).
69. It is not clear whether the nondiscrimination clause applies to health plans that are grandfathered
into the ACA scheme. See Grandfathered Health Plans, U.S. DEP'T OF HEALTH & HuMAN SERVS. (Aug. 20,
2012), available at http://www.healthcare.gov/law/features/rights/grandfathered-plans/index.html. For a very
strong endorsement of § 2706 as opening the door to CAM coverage, see Daniel Redwood, Provider Nondiscrim-
ination Update, 6 HEALTH INSIGHTs TODAY 1 (2013), available at http://www.cleveland.edu/hit/janfeb-2013-vol-
6-no-1/editors-log-provider-nondiscrimination-update/.
70. See Patient Protection and Affordable Care Act; Establishment of the Multi-State Plan Program for
the Affordable Insurance Exchanges, 78 Fed. Reg.15560 (March 11,2013).
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may create mandates for health insur-
ance exchanges and Medicaid expansions
that require parallel nondiscrimination
provisions for health plans that meet
state standards.71 Undoubtedly, nondis-
crimination requirements advance the
uses of licensed CAM, but do so in a
rather indirect manner. In particular, the
practical importance of Section 2706 is
ambiguous in that it must be viewed in
reference to the minimum essential bene-
fit requirements mandated under the
ACA.72 As such, the services afforded by
the licensed CAM provider must fit
within the scopes of practice of individual
categories that are licensed or certified by
a given state. Scope of practice issues can
be sorted out, but coverage in this context
will not be based simply around value-ad-
ded assessments or non-discrimination
principles; instead, it will be locked in the
professionalscuffles between allopathic
and alternative practitioners.73 The im-
plications of nondiscrimination enforce-
ment have not been lost on organized
medicine. The American Medical Associa-
tion Board of Trustees has gone on record
to oppose what they perceive to be the po-
tential for inappropriate expansion of
non-physician services and to call for the
repeal of Section 2706.74
B. Elements of a Conventional
Case
The ACA may advance the case for
CAM inclusion within the context of sev-
eral sections of the law as noted, and at
the end of the day, those statutory expan-
sions may be the most realistic vehicle to
regularize the use of non-traditional
medicine in the context of our evolving
delivery system. This is not to suggest,
however, that the development of a con-
certed public policy that directly ad-
dresses the presence of CAM and
deliberately builds a case for its use, al-
beit a modest one, should not be pursued,
independent of the ACA provisions.75
Given the vicissitudes of statutory inter-
pretation and the ambiguities in harmo-
71. For example, Hawaii and California both require that acupuncture be a covered service for plans
listed on the respective state exchanges. See also CRS Section 10-16-107.7 that creates a provider non-discrim-
ination provision for chiropractors, explains in the Colorado Division of Insurance Bulletin No. B-4.60, May 29,2013.
72. See 42 U.S.C. § 18021 (2010). There are ten broad categories of coverage under the ACA: hospitaliza-
tion, emergency services, maternity and newborn, prescription drugs, rehabilitative and habilitative services
and devices, laboratory services, preventive and wellness services and chronic disease management, and pedi-
atric services, including oral and vision care.
73. See Maguire v. Thompson, 957 F.2d 374 (7th Cir. 1992), a case which typifies both the many battles
fought by CAM providers against allopathic medicine and the disputes that can be found in an array of CAM
disciplines.
74. See Steven J. Stack, Report of the Board of Trustees; Patient Protection and Affordable Care Act
Nondiscrimination Language, Am. MED. Ass'N, available at http://newsfromaoa.files.wordpress.com/2012/10/
il2-bot-report-08.pdf.
75. This area of CAM is highly politicized and has been a long-standing battleground in the annals of
American health care. We have come a long way since the days of Wilk v. Am. Med. Ass'n, 895 F.2d 352 (7th
Cir. 1990), but there is still great tension between biomedical and CAM approaches to health care that make
expansion in insurance coverage for non-traditional health practitioners a matter that will likely be ap-
proached in the shadows of the federal regulatory system and the hallways of state government.
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nizing CAM expansions with state scope
of practice provisions, a more generic
case for non-traditional medicine is still
foundational to any consideration of ex-
pansion in this area. Constructing a case
for a more inclusive use of CAM is hardly
a new exercise, as that ground has been
plowed many times before. 7 6 But as the
landscape of health care has changed, it
is important to reconsider core elements
in building a case for CAM in the midst of
reform implementations. There are four
factors that are timely and salient in the
current consideration of regularizing the
use of CAM: licensure, reimbursement,
clinical effectiveness research and pa-
tient satisfaction.
The history of CAM is one deeply
rooted in the politics and legalities of li-
censing, as the struggles for professional
recognition of non-allopathic practition-
ers have been focused on gaining legiti-
macy and distinction through this very
basic regulatory process.7 7 Aside from be-
ing fundamental to official recognition,
the existence of licensed status also al-
lows a group of health providers to offer
distinct services that are separate from
the practice of medicine, shielding them
from the possibility of state sanction cur-
rently imposed upon traditional licensees
for medical practice.7 8 Professional licens-
ing, at its core, is a legal mechanism
rooted in state police power and govern-
ment obligation, and it is used as a mech-
anism that safeguards the public by
setting conditions on education, charac-
ter and the scope and nature of services
provided by licensees.7 9 While profes-
sional licensure has been widely criti-
cized as being ineffective, it nevertheless
is a legal standard that sets the founda-
tions that allow a given enterprise to ex-
ist and to create a requisite professional
organization.so Undoubtedly, state legis-
latures, empowered with the authority to
76. See generally MICHAEL H. COHEN, COMPLEMENTARY AND ALTERNATIVE MEDICINE: LEGAL BOUNDARIES
AND REGULATORY PERSPECTIVES (1998). See also JOSEPH C. KEATING, JR. & DONNA M. LIEWER, PROTECTION,
REGULATION & LEGITIMACY: FCLB & THE STORY OF LICENSING IN CHIROPRACTIC (2012).
77. See id.
78. See, e.g., Authority to Require Medical Liability Insurance, Op. Att'y Gen. Fla. 078-25 (1978). See
generally Maguire v. Thompson, 957 F.2d 374 (7th Cir. 1992). Maguire involved a challenge by three
naprapaths against their exclusion to practice under the Illinois Medical Practice Act (IMPA). The case
presents an interesting chronicle of the struggles of one CAM group, naprapaths, to gain inclusion in the
Medical Practice Act scheme. It is noteworthy that the IMPA creates two categories of medical license: first, a
traditional license to practice medicine generally, and second, a tier of license to treat human ailments without
drug or operative surgery. The fact that a particular group is trained to practice without drugs or surgery does
not automatically qualify them for the more limited medical licensure, as Maguire illustrates.
79. See Edward Richards, The Police Power and the Regulation of Medical Practice: A Historical Review
and Guide for Medical Licensing Board Regulation ofPhysicians in ERISA-Qualified Managed Care Organiza-
tions, 8 ANNALS HEALTH LAw 201, 202-23 (1999).
80. See William P. Gunnar, The Scope of a Physician's Medical Practice: Is the Public Adequately Pro-
tected by State Medical Licensure, Peer Review and the National Practitioner Data Bank?, 14 ANNALS HEALTH
LAw 329, 332-41 (2005). See also Richard P. Kusserow, State Licensure and Discipline of Chiropractors, OFFICE
OF INSPECTOR GENERAL 1, 8-13 (Jan. 1989), available at https://oig.hhs.gov/oei/reports/oai-01-88-00581.pdf (dis-
cussing licensure). A considerable amount of the criticism about licensure and scope of practice is found in the
myriad of battles fought by one group of practitioners who, for professional and economic reasons, fight hard to
discredit areas of practice that abut and infringe on a given group's ambit of operation. See generally Peter
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license, are often not rigorous bodies of
scientific analyses, but until a more effec-
tive litmus test is created, such legal rec-
ognition should be viewed as pivotal in
establishing the legitimacy of respective
CAM providers.8 1 In particular, the li-
censed categories of CAM that are estab-
lished as independent and distinct from
medical doctors present a strong case
based on this legal status for a meaning-
ful inclusion in the public health enter-
prise.82
While licensure may add legal legiti-
macy and a degree of public protection to
a given CAM profession, it is seen as a
baseline requirement, as evidenced by
the proliferation of certification and
credentialing processes characteristic of
most health professions. Further, al-
though licensure acts as a foundational
requirement for public and private health
insurance payment, the fact that a given
provider is licensed does not lead to a
guarantee of payment for a particular
service. By law, health insurance plans
are required to cover certain mandated
services, but it becomes a matter of dis-
cretion for the insurer to determine what
areas of treatment will be covered based
on an analysis of what is reasonable, nec-
essary, and not experimental."1 Gener-
ally, for most traditional medical
services, coverage decisions of medical
necessity rest on the practices of local
physicians, and it is the exceptional ser-
vice that triggers intensive coverage re-
view and analyses based largely on
concerns over volume and cost.84 CAM
presents a difficult challenge for health
insurance plans that are focused on offer-
ing payment for standard biomedical ser-
vices. Non-traditional health services
may not fit into a rubric of experimenta-
tion; they are expenditures that may ap-
pear unreasonable and largely unproven
when measured against a litmus tests of
Huijbregts, Chiropractic Legal Challenges to the Physical Therapy Scope of Practice: Anybody Else Taking the
Ethical High Ground?, 12 J. MANUAL & MANIPULATIVE THERAPY 69, 69-80 (2007), available at http://www.ncbi
.nlm.nih.gov/pmc/articles/PMC2565606/pdfljmmtOO15-0069.pdf.
81. See Cohen, supra note 76, at 26-29 (providing examples of the various definitions of the practice of
medicine in states' medical licensing statutes).
82. Some licensed CAM providers have their own regulatory boards, which clearly creates greater legiti-
macy and autonomy, while other groups may be regulated under a state medical board. See, e.g., Doctors of
Naprapathy, N.M. MED. BOARD, available at http://www.nmmb.state.nm.us/naprapathy.html.
83. For a detailed description of federal coverage policy for Medicare Part B, in which the array of ser-
vices covered through this part of Medicare are detailed, see Medicare Benefit Policy Manual: Chapter 15 -
Covered Medical and Other Health Services, CTR. FOR MEDICARE & MEDICAID SERvS. (Oct. 26, 2012), available
at http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/bpl02cl5.pdf (discussing cov-
erage of chiropractic services in section 30.5, which is specifically restricted to licensed or legally authorized
chiropractors who are covered only for manual manipulation of the spine). See also Barbara L. Atwell, Main-
streaming Complementary and Alternative Medicine in the Face of Uncertainty, 72 UMKC L. REV. 593, 598-600
(2004) (presenting the issue of health insurers' broad discretion in determining whether a patient's treatment
is necessary, unnecessary or experimental) (hereinafter Atwell).
84. See, e.g., Medicare National Coverage Determinations Manual, CTR. FOR MEDICARE & MEDICAID
SERvS., available at http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/ncdl03cl
Partl.pdf; Report to the Congress: Medicare Payment Policy, Appendix B: An introduction to How Medicare
Makes Coverage Decisions, MEDPAC (Mar. 2003), available at http://www.medpac.gov/publications/congression
al-reports/Mar03_AppB.pdf.
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allopathic medicine. And yet, over the
course of many years, there has been a
gradual expansion of insurance coverage
for CAM, which is based on a combina-
tion of factors, including cost-effective-
ness, consumer demand, and employer
support for wellness and anti-discrimina-
tion laws." Although insurance coverage
for CAM is still quite limited at this
point, even narrow coverage provides cer-
tain de facto validity to such services.86
The best way for CAM to distinguish
itself as an area that should engender
further inclusion is through demonstra-
tion of validity via traditional clinical ef-
fectiveness studies. 7 The fact that a
great deal of conventional health care has
not been subjected to rigorous assess-
ment does not diminish the need for non-
traditional medicine to make its case
through current evidence-based studies,
as such pressure is being exerted on all
areas of health delivery.- One of the un-
derlying goals of the ACA is to improve
the base of medical knowledge concerning
therapeutic interventions, 89 harnessing a
long-standing goal of health services re-
search dating back to the early part of the
20th century. In reference to CAM evalu-
ation, the foundational purpose of the
National Center for Complementary and
Alternative Medicine (NCCAM), which is
a medical research agency within the Na-
tional Institutes of Health, is to sponsor
research on the effectiveness of CAM
therapies. 90 While there have been impor-
tant studies on various aspects of CAM
that have shown positive results for a
85. See Paying for CAM Treatment, NAT'L CTR. FOR COMPLEMENTARY AND ALTERNATIVE MED. (July 2011),
available at http://nceam.nih.gov/health/financial; see also Jennifer Jo Thompson & Mark Nichter, Comple-
mentary & Alternative Medicine in the US Health Insurance Reform Debate: An Anthropological Assessment is
Warranted, Soc'Y FOR MED. ANTHROPOLOGY (2011), available at http://medanthro.net/research/cagh/insurance-
statements/Thompson&Nichter(CAM).pdf (suggesting an anthropological assessment of health insurance cov-
erage as it pertains to CAM with the passage of the Affordable Care Act) (hereinafter Thompson & Nichter);
Cathy Wong, Getting Insurance for Alternative Medicine, ABOUT.COM (Sept. 24, 2012), http://altmedicine.about
.com/od/sortoutyouroptions/a/altmedinsurance.htm (providing a consumer-oriented guide to CAM and health
insurance).
86. See Atwell, supra note 83, at 610-12 (noting that while insurance coverage for conventional treat-
ments is more readily available, many states recognize the validity of CAM treatments through educational
and licensing requirements).
87. Scientific evidence on complementary medicine includes results from laboratory research (e.g.,
animal studies) as well as clinical trials (studies with people). It encompasses both "positive" findings (evidence
that an approach may work) and "negative" findings (evidence that it probably does not work or that it may be
unsafe). Scientific journals publish study results as well as review articles that evaluate the evidence as it
accumulates. NCCAM fact sheets on specific health conditions or complementary approaches base information
about research findings primarily on the most rigorous review articles, known as systematic reviews and meta-
analyses. Authors of such reviews often conclude that more research and/or better-designed studies are
needed. See National Center for Complementary and Alternative Medicine, Exploring the Science of Comple-
mentary and Alternative Medicine, U.S. DEP'T OF HEALTH & HUMAN SERVs. 1, 5-6, available at http://www
.nccam.nih.gov/sites/nccam.nih.gov/files/about/plans/2011/NCCAMSP_508.pdf.
88. See id. at 50.
89. See The Ethics of Health Care Reform: Issues in Emergency - Medicine - An Information Paper, AM.
COLL. OF EMERGENCY PHYsIciANs, available at http://www.acep.org/Content.aspx?id=80871.
90. Nat'l Insts. of Health, NCCAM Facts-at-a-Glance and Mission, U.S. DEP'T OF HEALTH & HUMAN
SERVS., (Sept. 6, 2012), available at http://www.nccam.nih.gov/about/ataglance.
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number of therapies, the overwhelming
body of clinical effectiveness research has
not been dramatically conclusive.9' There
is also considerable controversy sur-
rounding clinical studies that claim the
impact of a given therapy is psychological
and that a placebo effect is a legitimate,
positive outcome of a health interven-
tion.92 It has been suggested by one com-
mentator that the evaluative mechanism
for CAM therapies be based on a concept
of reasonableness framed within a uni-
verse of professional opinion that extends
to licensed health professionals more
broadly.93 Undoubtedly, it would be help-
ful to introduce more liberal and innova-
tive approaches to the assessment of
health care services, but such changes
must be acceptable to traditional
medicine and fit within the current con-
cepts of health services research. CAM
practices will continue to face the chal-
lenges of demonstrating efficacy in the
world of conventional science and must,
in addition to forging new approaches to
quality assessment, seize on positive
findings that fit within current biomedi-
cal evaluation formats.
Questions of deciphering clinical effi-
cacy are not static and clearly relate to
broader trends across health services re-
search generally. We have entered a pe-
riod of dramatic change in the practice of
medicine as traditional health care prov-
iders are grappling with deciphering the
appropriate treatments in the face of in-
tersecting cost and quality pressures.9 4
Long standing concerns over quality and
appropriateness in traditional medicine
have spawned a change in clinical effec-
tiveness research that not only supports
traditional scientific approaches, but has
led to an increasing awareness that ques-
tions of deciphering appropriate medical
care need to be assessed from a patient-
oriented perspective.-5 The ACA, as pre-
viously noted, created the PCORI to sup-
port and promote clinical effectiveness
studies that help fill the void in providing
clinical data on medical procedures that
are oriented toward supporting the inter-
ests of individuals and families. PCORI
represents the most current iteration of a
91. For an interesting view of CAM from an international perspective, which points out the need for more
research and coordination of CAM generally, see The Roadmap for European CAM Research: An Explanation of
the CAMbrella Project and its Key Findings, CAMBRELLA 1, 45-51 (Dec. 2012), http://www.cambrella.eu/
aduploads/cambrellaroadmap.pdf.
92. See Harald Walach, The Efficacy Paradox in Randomized Controlled Trials of CAM and Elsewhere:
Beware of the Placebo Trap, 7 J. ALT. AND COMPLEMENTARY MED. 213, 213-217 (2001), http://www.chiro.org/
research/FULL/ThePlacebo Trap.pdf.
93. See Atwell, supra note 83, at 623-29 (suggesting a paradigm shift in the insurance reimbursement
standard from medical necessity to reasonable necessity).
94. See Victor P. Fuchs, The Doctor's Dilemma - What is "Appropriate" Care?, 365 NEW ENG. J. MED. 585,
585-87 (Aug. 18, 2011), available at http://www.nejm.org/doi/pdf/10.1056/NEJMp1107283 (discussing the bal-
ancing act doctors currently face in regards to patient welfare and cost-effective treatment).
95. See A. Eugene Washington & Steven H. Lipstein, The Patient Centered Outcomes Research Institute -
Promoting Better Information, Decisions, and Health, 365 NEw ENG. J. MED. E31(1), E31(1)-E31(3) (Oct. 13,
2011), available at http://www.nejm.org/doi/pdf/10.1056/NEJMp11O9407 (providing on overview of the PCORI,
newly created by the Affordable Care Act).
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movement toward patient-centeredness
in clinical efficacy evaluations and fits
into the broader context of framing con-
siderations of appropriateness into in-
quiries directed to patient engagement.96
There has been a focus on consumerism
in health delivery for some time, but the
newer emphasis on patients' concerns in-
volves active engagement in treatment
that may result in better outcomes, hope-
fully at lower costs.9 7 A patient-centered
outcomes emphasis is a favorable arena
for CAM therapies that promote health in
areas such as mood disorder and chronic
pain, where subjective determinations
are necessary markers.98 In addition, pa-
tient satisfaction in CAM therapy can be
further validated by cost data that dem-
onstrates that more conservative comple-
mentary approaches to illness may hold
considerable promise for reducing ex-
penditures.9 9
IV. Innovation
The case for a more inclusive use of
CAM can be made specifically on the ba-
sis of the ACA's nondiscrimination provi-
sion, as well as on the four broader
elements noted: licensure, reimburse-
ment, clinical effectiveness research and
patient-centeredness. A more generic
case for use of CAM can be built upon the
need for an enhanced complement of
health professionals to address the macro
issues of health reform. In particular, the
96. PCORI is directed toward data generation that can be used by patients. It is not directed toward
CAM, per se, but clearly will consider licensed CAM therapies, as indicated by its grant program. See, e.g., A
Comparison ofNon-Surgical Treatment Methods for Patients with Lumbar Spinal Stenosis, PATIENT-CENTERED
OUTCOMES RES. INST., available at http://www.pcori.org/cyclel/a-comparison-of-non-surgical-treatment-meth-
ods-for-patients-with-lumbar-spinal-stenosis/ (implementing a manual therapy as one of three comparative
therapies in the study); see also Evaluation of a Patient-Centered Risk Stratification Method for Improving
Primary Care for Back Pain, PATIENT-CENTERED OUTCOMES RES. INST., available at http://www.pcori.org/cy-
clel/evaluation-of-a-patient-centered-risk-stratification-method-for-improving-primary-care-for-back-pain/.
97. Karen Caffarini, Patient-centered Care Found to Reduce Medical Costs, AM. MED. NEWS (July 18,
2011) http://www.amednews.com/article/20110718/business/307189961/7/ (referring to a UC Davis study that
found when physicians have more personalized discussions with patients, it may help to reduce health care
costs). Consumerism in health care has a long and diverse history. There have been a number of measures
developed to assess the nature of patient experiences with the health system, such as the Consumer Assess-
ment of Healthcare Providers and Systems (CAHPS), that provide helpful measurements but are more ori-
ented to the treatment process than the clinical outcomes. See About CAHPS, AGENCY FOR HEALTHCARE RES.
AND QUALITY, http://cahps.ahrq.gov/about.htm (last visited Mar. 23, 2013). In addition, there is a movement to
provide greater consumer choice in selecting alternative medicine practitioners, which is directed toward over-
coming barriers in licensing and related scope-of-practice restrictions. Such laws essentially allow unlicensed
CAM practitioners to function without licenses so as not to deny consumers a right to utilize such services. See,
e.g., N. M. Unlicensed Healthcare Practice Act, N.M. STAT. ANN. §§ 61-35-1 to 61-35-8 (2009).
98. See LESLIE T. FOSTER & C. PETER KELLER, THE BRITISH COLUMBIA ATLAS OF WELLNESS 9-19 (1st ed.
2007) available at http://www.geog.uvic.ca/wellness/wellness/2_DefiningWellness.pdf (discussing how to define
wellness from various perspectives and focusing on the subjective concept of health and wellness).
99. See Thompson & Nichter, supra note 85, at 3-4 ("Individuals with chronic disease are more likely to
use CAM than those without chronic disease, and there is some evidence that it may also be cost-effective to
cover CAM therapies or offer 'integrated' CAM and biomedical care for chronic disease management."). CAM is
often not an "either-or" prospect, as such services are often a complement to traditional therapy. If such ap-
proaches can forestall or circumvent more costly therapies, whether drug therapy or surgical intervention,
they may prove economically viable.
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use of CAM can address the need for
healthcare professionals to meet what is
arguably the ACA's biggest cost and qual-
ity challenge: problems of chronic illness
and chronic pain. Undoubtedly, the ACA
lays out many pathways to meet immedi-
ate and long-term issues in chronic ill-
ness, but as the issues presented are
large and diverse, solutions need to be
broad and inclusive while utilizing credi-
ble resources that are available and cost-
effective.
The stock and trade of the ACA and
the regulatory and policy issues that sur-
round it are frequently characterized by
the concept of innovation. 00 The ACA in-
cludes multiple initiatives to reform the
delivery system, address quality and
safety issues, and improve regulatory
oversight and program integrity repre-
sented by a myriad of provisions that in-
dividually and collectively constitute
considerable innovation in health policy.
While many signature elements can be
used to characterize the ACA's vision of
health care delivery, the sum total of its
many parts move health care from a si-
loed and disjointed enterprise into one
that is more coordinated and integrated.
The operational formats of health care in
the post-ACA era are evolving, and in
some cases are ill-defined, but the policy
makers' goals of transformation and in-
novation aspire toward a more cost-effec-
tive and cohesive delivery system
composed of models that rearrange the
existing system and utilize current medi-
cal standards and technology supports.
The new models of care that will emerge
from the ACA may constitute a creative
restructuring of pieces of the biomedical
care system. Ultimately, innovation is
constricted by traditional views of health-
care that rely on powerful mechanisms of
control and uniformity. This, at best,
presents grudging opportunities for
changes that deviate from allopathic
frameworks of medical care.
A. The Naprapath in the
Rainforest
Although transformation and innova-
tion are goals of the health care system,
the need exists for a wider tolerance for
creative approaches to health problems
than ones that emerge from ACA devel-
opments. It would be wise for health care
policy makers to draw lessons from inno-
vations in other industries that allow for
greater flexibility, experimentation, and,
in particular, a more inclusive use of non-
traditional licensed health providers. In
2012, Victor W. Hwang and Greg
Horowitt presented a compelling analysis
of factors that make corporations innova-
100. See, e.g., Wendy Everett, Innovation is Key to Controlling Health Care Costs, THE HEALTH CARE
BLOG (June 26, 2012), http://thehealthcareblog.com/blog/2012/06/26/innovation-is-key-to-controlling-health-
care-costs/; Better Health, Better Care, Lower Costs: Reforming Health Care Delivery, U.S. DEP'T OF HEALTH &
HUMAN SERVS. (July 27, 2011), available at http://www.healthcare.gov/news/factsheets/2011/07/deliverysystem
07272011a.html; Barbara Ballard, Innovative Strategies Needed to Implement Affordable Care Act, THE Hur.
FINGTON PosT (Sept. 26, 2012, 12:27 PM), http://www.huffingtonpost.com/barbara-ballard/implementing-the-af
fordable-care-act b_1910621.html; Office of the Press Secretary, FACT SHEET: The Affordable Care Act: Sup-
porting Innovation, Empowering States, THE WHITE HOUSE (Feb. 28, 2011), available at http://www.white
house.gov/the-press-office/2011/02/28/fact-sheet-affordable-care-act-supporting-innovation-empowering-states.
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tive in their book The Rainforest: The Se-
cret to Building the Next Silicon Valley
(hereinafter The Rainforest).'0 The au-
thors of The Rainforest argue that suc-
cessful change and innovation occurs in
organizations that often bring together
unlikely groups of professionals to ad-
dress common problems, and such un-
likely combinations foster innovations. 10 2
Unconventional structures that are
forged around cross-disciplinary perspec-
tives, according to Hwang and Horowitt,
result in fluid structures that are ori-
ented toward outcomes as opposed to
processes. 1 0 3 Under The Rainforest view,
transformation comes from environments
that are fluid and freer to select diverse
processes to achieve outcomes.' 0 4 Hwang
and Horowitt characterize organizations
that lack innovation as being entities
that that are focused on controlling com-
plex systems with very technical mea-
sures of productivity designed to spawn
efficiency and produce more optimal out-
puts.105 Transformation within the ACA
context does not appear to be moving to-
ward the model envisioned in The
Rainforest, but is, instead, heavily
weighted toward reinventing healthcare
to have it fit into newer, and hopefully
more efficient, structures of delivery that
share common goals of coordination,
quality, and efficiency. While the rhetoric
of innovation in the ACA arena is deep,
the outputs of CMS mandates are highly
detailed and very prescriptive, placing
the boundaries of creativity within tradi-
tional and cautious administrative con-
structs.
B. The Parameters of a Model
for Modest Innovation
It is unrealistic to expect health care
policy makers to adopt an approach to in-
novation that would parallel the open-en-
ded nature of corporate innovation seen
in Silicon Valley, particularly in the con-
text of such a regulated industry as
healthcare. Nonetheless, as innovation
and transformation are central goals of
health reform, the ACA must be imple-
mented as a law that not only allows, but
also fosters real creative changes and
ideas like those discussed in The
Rainforest. Such ideas should not be
summarily dismissed. To date, the sum
total of regulation in the most innovative
sections of the ACA, like Accountable
Care Organizations (ACOs) and Value-
Based Purchasing (VBP), do not bode
well for the creation of a system that em-
braces changes unbridled by extreme
technicality and not supported by the ac-
quiescence of the hierarchy of health ser-
vices research. As noted, licensed CAM
101. See VICTOR W. HWANG & GREG HOROWYTr, THE RAINFOREST: THE SECRET TO BUILDING THE NEXT
SILICON VALLEY (2012).
102. For an excellent summary of the arguments presented in The Rainforest, see Lisa Canning, The
Value of Oddballs or How "Chicago Thinking" Explains Silicon Valley, ENTREPRENEUR THE ARTs (Mar. 29,
2012), http://blog.entrepreneurthearts.com/2012/03/29/the-value-of-oddballs-or-how-%E2%80%9Cchicago-
thinkingE2%80%9D-explains-silicon-valley/.
103. See id.
104. See id.
105. See id.
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providers may find an enhanced role
under the ACA. However, it is one driven
by statutory inclusion that lies outside
the realm of deliberate innovation. More-
over, the limited statutory expansions of
CAM appear to be largely devoid of regu-
latory visions of systemic transformation.
In light of the public health pressures
noted in this piece, broader system re-
structuring could be sparked by creative,
albeit non-conventional, reform measures
that draw on a wider array of licensed
health professionals and are more toler-
ant of organizations akin to those dis-
cussed in The Rainforest (ones that focus
more on outcomes than process and allow
for unconventional couplings of health
professionals).
The idea of devising more creative
and innovative health systems beyond
the conventions of unfolding reforms, or
finding the naprapath in the healthcare
rainforest, is constricted by political reali-
ties and rigid oversight. But the level of
uncertainty concerning conventional
health reforms, bolstered by wide-spread
agreement of the necessity for change,
fosters a favorable climate for innovators.
It is time for CAM providers to seize the
opportunity and make a renewed case for
inclusion. Such a case needs to be more
than rhetorical, but must be specific and
molded around programmatic elements
and goals of the ACA. As such, the case
for CAM must fit into the broad parame-
ters of cost-effectiveness and the en-
hancement of efficiency in an area of need
and it should be collaborative and pa-
tient-centric o6 It is essential that CAM
licensure, however imperfect, be used as
the baseline for expansion of services, as
lack of such status results in an expan-
sion to any form of CAM, which is too ill-
defined and amorphous to be efficiently
incorporated into a delivery system.
In addition, CAM licensing proce-
dures at the state level must be subjected
to meaningful evaluations to insure that
professional oversights are rigorous and
timely. Expanding the use of licensed
CAM should not be a way to make such
practitioners a type of primary care doc-
tor who is placed on a trajectory similar
to the path followed by osteopathic physi-
cians. o7 The benefits underlying CAM
therapists should be extracted from dif-
ferences in their approaches to healing
and wellness, and inclusion should
neither create junior allopathic physi-
cians nor result in scope-of-practice ex-
pansions that include prescribing
authority. Like other areas of health
care, the quality of CAM must be rooted
in efficacy and a discernible level of satis-
faction for patients. Patient satisfaction
does not merely require affording individ-
uals and families with better decision-
making tools, but it also involves requir-
ing a genuine level of acceptance and sup-
port from patients that undergo
24
106. It may be naive to imagine that any expansion of CAM will not trigger negative responses from
certain or all sectors of organized medicine, but certainly as the inclusion of CAM is considered, strategies to
minimize such conflicts, particularly in the scope of the practice area, must be found.
107. See NORMAN GEVITZ, THE DOs: OSTEOPATHIC MEDICINE IN AMERICA, 162 (2004).
John D. Blum
treatment.10 Creative uses of CAM must
be forged within the realities of reim-
bursement, recognizing the centrality of
payment to any type of health reform. Li-
censed CAM therapists should be incor-
porated into collaborative group practices
under a bundled payment system that
would promote divisions in provider re-
imbursement that are based on trust and
cross-disciplinary assessments of
value.'o
C. A Modest Rainforest
One pathway that lends itself to inno-
vative uses of CAM can be drawn from
the ACA's emphasis on the patient-cen-
tered medical homes (PCMH), recogniz-
ing that the ACA has paved the way for
CAM via the funding of grants for com-
munity health teams that include CAM
practitioners. 0 While medical homes can
follow various models, at their core they
are primary-care, collaborative medical
practices that use a team of health pro-
fessionals to provide patient-centric care
that is coordinated overtime and not epi-
sodic in nature." A key concept of the
medical home is that the structure deals
with patients across the life continuum,
and in addition to a focus on acute and
end-of-life care, the model is very directed
toward prevention, wellness, and chronic-
care management.112 While physician-led,
the PCMH is already characterized by
both its utilization of a complement of li-
censed health professionals and its incor-
poration of non-licensed personnel
(particularly community health workers),
as well as its recognized, potential exten-
sion into inter-professional collabora-
tion." 3 The goal of the medical home is to
more effectively use primary care physi-
cians, and the use of non-medical person-
nel becomes a vehicle to shift tasks and
108. It may seem extreme, but the system should move toward a goal of patient happiness. See Health-
care Happiness: Key to Creating a Patient-Centric Healthcare Organization, PATIENT-CENTERED OUTCOMES
RES. INST., available at http://www.pcori.org/assets/PFA-Awards-Cycle-1-2012.pdf.
109. Clearly, Section 3502 of the ACA, which allows for grant funding to create Community Health
Teams in conjunction with the patient-centered medical home, begins to move in the right direction for pur-
poses of integration of CAM therapists with primary care medicine. See Establishing Community Health
Teams to Support the Patient-Centered Medical Home, NEV. DEP'T. OF HEALTH & HuMAN SERVS., available at
http://dhhs.nv.gov/HealthCare/Docs/NVPolicyPapers/Section_3502 PCMHCommunityHealthTeams.pdf.
110. See 42 U.S.C. 256a-1 § 3502 (2010); see also Jill Bernstein, Deborah Chollet, Deborah Peikes, & G.
Gregory Peterson, Medical Homes: Will They Improve Primary Care?, 6 MATHEMATICA POL'Y RESEARCH, INC. 1,
4 (June 2010), available at http://www.mathematica-mpr.com/publications/PDFs/HealthlReformhealthcare
IB6.pdf.
111. See generally A New Model of Care Delivery: Patient-Centered Medical Homes Enhance Primary
Care Practice, NCQA, available at http://www.ncqa.org/Portals/O/PCMH%20brochure-web.pdf.
112. See Gregory Burke, The Patient-Centered Medical Home: Taking a Model to Scale in New York
State, UNITED HOSPITAL FUND (2011), available at http://www.acponline.orgladvocacy/state-health-policy/re-
ports/taking-a model-to-scale.pdf.
113. See Defining the Medical Home, A Patient-Centered Philosophy that Drives Primary Care Excellence,
PATIENT-CENTERED PRIMARY CARE COLLABORATIVE, http://www.pcpcc.net/about/medical-home (last visited Mar.
30 2013). In regards to community health workers, see generally Kelly Volkmann & Tina Castaneras, Clinical
Community Health Workers, Linchpin of the Medical Home, 34 J. OF AMBULATORY CARE MGMT. 221 (July
2011), available at http://www.ncbi.nlm.nih.gov/pubmed/21673521. See also 42 U.S.C. 256a-1 § 3502 (2010)
(stating that grants are made available for inter-professional teams to deal with chronic illness).
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reduce inefficiencies in the deployment of
primary care physicians.114 While PCMH
models are a growing presence around
the country, these models are still evolv-
ing and are conceptually fluid enough to
meet patient needs in prevention and
chronic care through use of creative com-
plements of licensed personnel outside of
traditional physician extenders. To an ex-
tent, CAM integrative practices devel-
oped in the last twenty years, have paved
the way for PCMHs that include non-
traditional providers, and are often lo-
cated at major medical centers.115 What is
distinct about CAM providers being in-
corporated into PCMHs, beyond prior in-
tegrated practices, is that such
incorporation can be more central and fo-
cused on addressing targeted chronic ill-
nesses in which CAM therapy is the
primary treatment modality as opposed
to being a complementary or alternative
set of services.n1e
The question then arises as to how
CAM can be integrated meaningfully into
a PCMH model. To be meaningful, the
construction of an applied model for CAM
should be targeted to a core area of need
and should fit within a particular priority
of the ACA. Undoubtedly, multiple
problems could serve as a springboard on
which to bring CAM together with allo-
pathic medicine, but whatever area is
chosen, beyond meeting broad public
needs, it must be defined, safe, and able
to meet some litmus test for quality, and
it must represent a cost-effective alterna-
tive. Cycling back to the prior discussion,
a major area of challenge in chronic dis-
ease is confronted in the area of pain
management, and even more specifically,
chronic lower back pain." 7 Chronic lower
back pain presents a costly and difficult
problem that would be an ideal focal
point for integrating licensed CAM spe-
cialists in manipulative therapy into
more mainstream use, and it already en-
joys a certain level of acceptability in allo-
pathic circles. For example, a naprapath
who specializes in connective tissue dis-
orders, a form of manipulative medicine,
could provide drug-free therapy for lower
back pain in conjunction with a physi-
cian-directed provider team, not as a
complement of care, but rather as the
first-line care giver.
Naprapathy, and other licensed ma-
nipulative therapists, offer alternatives
for back pain at much lower costs than
medical intervention while enjoying
strong patient support. For reimburse-
ment purposes, the use of bundled pay-
ment in a non-traditional medicine area
can move licensed CAM away from the
114. See Rebecca Onie, Paul Farmer & Heidi Behforouz, Realigning Health with Care: Lessons in Deliv-
ering More with Less, 13 STANFORD Soc. INNOVATION REV. 27, 32 (2012).
115. There are different groups that claim to represent integrative practices that blend traditional
medicine with CAM. The most traditional organization in the integrative practice area is the Consortium of
Academic Health Centers for Integrative Medicine, which is composed of programs at large medical centers.
See CONSORTIUM OF ACADEMIc HEALTH CTRS. FOR INTEGRATIVE MED., http://www.imconsortium.org/about/home
.html (last visited Mar. 26, 2013).
116. See generally Living Well with Chronic Illness, supra note 38.
117. See Low Back Pain Fact Sheet, NAT'L INST. OF NEUROLOGICAL DISORDERS AND STROKE (July 2003),
available at http://www.ninds.nih.gov/disorders/backpain/detail-backpain.htm.
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world of strict and awkward billing codes
and place the burden of reimbursement
equity on individual PCMHs.11" No doubt
any inclusion of CAM, for pain or any
other chronic illness, will come with a
reasonable call for a demonstration of ef-
ficacy and quality effectiveness. Clinical
efficacy studies for CAM have been slow
to demonstrate broad utility, but an inte-
grated PCMH model for back pain would
provide an applied setting that would fos-
ter cross-disciplinary evaluations. Formal
quality measurement programs could be
developed by each PCMH, targeting an
area such as lower back pain and devel-
oping individual approaches to assess-
ment based on the models used in the
Medicare Quality Assurance Improve-
ment Program (QAPI) that are more self-
directed.119
Expanding the ambit of PCMHs into
CAM integration in the area of chronic
back pain is a small and incremental
step, but innovation outside of convention
must be approached cautiously. Undoubt-
edly, non-traditional medicine advocates
may wish to see a more expansive ap-
proach to legitimizing the use of CAM
therapies in the ACA context, one that
goes beyond a narrowly-tailored plan for
inclusion in the area of chronic back pain;
consequentially, further innovations in
CAM as they relate to chronic illnesses
are likely.120 Others may scoff at the idea
of using licensed manipulative medicine
therapists under the umbrella of physi-
cian control as the type of innovation that
supports the analogy to corporate innova-
tions presented in The Rainforest.'2 1 Al-
though the model proposed herein is not
a dazzling innovation, it is practical one.
If licensed CAM therapists are to join
the mainstream of health, even in a time
of great need, their cases for advocating
such developments are best structured
within the context of conventional medi-
cal models. The PCMH is not a brand
new model, but it is one that affords a
logical and, hopefully, workable juncture
for coalescing licensed therapists around
back pain issues, which is an ideal target
area for innovation and has proven to be
a persistently illusive problem area. To a
large degree, the use of chronic back pain
as a test case for CAM serves to both for-
malize and restructure the realities of pa-
tient treatment patterns, and it could
serve as a springboard for greater inte-
gration in practice and perhaps even in
professional education. Back pain is not
an end point for integration, but rather a
tangible beginning in which the exper-
iences of an unlikely combination of prov-
iders can serve as an incubator for
further collaboration and innovation.
Even greater progress in inclusion can be
118. See Atwell, supra note 83, at 623-4. It is also possible to capitate integrated health care services
(rates based on diagnosis), but that requires a more definitive policy on reimbursement where rates are calcu-
lated prospectively and could be cast narrowly, not allowing adequate flexibility for non-physician services. A
bundled payment forces the provider group to determine reimbursement for team members based on an as-
sessment that is more localized and determinative of a value analysis that is distinct to the group in question
and unlike traditional capitation does not shift financial risk.
119. See A New Model of Care Delivery, supra note 111.
120. See, e.g., Atwell, supra note 83, at 630.
121. See HWANG & HoRowrrr, supra note 101; see also Canning, supra note 102.
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served in the future by crafting educa-
tional opportunities that bring together
students from diverse health professional
disciplines to focus on common problem
areas such as back pain. Clearly in the
maze of health care (i.e. the "rainforest"),
patients are already seeking out alterna-
tive therapists (i.e. the naprapaths of the
world) to obtain relief in the face of frus-
tration with conventional therapeutic op-
tions, and as such, broader CAM therapy
inclusion is a meaningful response to
broader public health needs.
V. Conclusion
The viability of the ACA rests on our
facing multiple challenges, including cost
containment, provisions of comprehen-
sive insurance that promote prevention
and wellness, and the dramatic and per-
sistent shortages in primary care. 1 22 In
the hierarchy of public health, no area is
more challenging than the macro and
micro issues faced in chronic illnesses.
Most apparent in this period of health-
care transformation is the notion that
multiple changes must occur, and that in
order for systemic reinvention to be feasi-
ble, a high level of innovation and crea-
tivity needs to be adopted in the health
delivery sector. The ACA lays out many
pathways for innovation, but those path-
ways may not be enough to address the
long list of public health problems. Inno-
vations that lie outside the boundaries of
reshaping the traditional delivery system
may be necessary, and resultant models
should not ignore the contributions of li-
censed health professionals across disci-
plines. It is counterproductive to support
open-ended innovation, but within the
frameworks of ACA changes, in particu-
lar patient-centered medical homes, ex-
periments in interdisciplinary practice
should be pursued, in particular, those
targeting chronic illness. Pain (specifi-
cally, chronic lower back pain) is a costly
and persistent issue, and it provides a
compelling area for incorporating li-
censed CAM providers in manipulative
therapy, serving as a cautious first step
out of the biomedical box. Finding the
"naprapath in the rainforest" of health
care developments is a small step, but it
is in such steps that real health care
transformation will occur.
122. See Annie Lowrey & Robert Pear, Doctor Shortage Likely to Worsen With Health Law, N.Y. TIMES,
Jul. 28, 2012, available at http://www.nytimes.com/2012/07/29/health/policy/too-few-doctors-in-many-us-com
munities.html? r=0; See also Michael J. Mishak, State Lacks Doctors to Meet Demand of National Healthcare
Law, Los ANGELES TIMEs, Feb. 9, 2013, available at http://articles.latimes.com/2013/feb/09/local/la-me-doctors-
20130210.
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